Cut the time and cost of antibody discovery with the negative pressure Beacon Select™ optofluidic system. This system uses Opto® B Discovery workflows to get you the best antibody lead candidates. By combining massive screening throughput for more shots on goal, function-first assays to funnel to only the best B cells, and high recovery rates of antibody sequences, users can obtain validated antibody sequences against even the hardest targets within 1-2 weeks.
Some of the features and benefits of this system include:
- Finding antibody sequences against rare targets where others can’t
- Tailoring your lead candidate discovery to any target and function, including functional blockers and the high-affinity molecules
- Discovering up to 10-fold more hits, access 50-fold greater sequence diversity, and reduce costs by 20-fold in a matter of days, not weeks